Company Market Research Report: Cytel Inc.

Company Overview

• Name: Cytel Inc.

• Mission: To unlock the power of data, empowering life science leaders to realize the full potential of therapies. The company strives to shorten the drug development cycle and increase the probability of success for better patient outcomes through pioneering data science and analytical methods.

• Founded: 1987

• Founders: Cyrus Mehta and Nitin Patel

• Key People:

• Cyrus Mehta, Co-Founder and President

• Nitin Patel, Co-Founder and Research Lead, Cytel Innovation Center

• Jovan Willford, Chief Executive Officer

• Jorge Gomez, Chief Financial Officer

• Michelle Hoiseth, Senior Vice President, General Manager of Project Based Analytical Services

• Yannis Jemiai, Chief Scientific Officer

• Headquarters: 675 Massachusetts Ave, Cambridge, MA 02139 USA

• Number of Employees: Over 2,000

• Revenue: No information is available

• Known For: Cytel is a leader in adaptive clinical trials, biostatistics, and data science solutions for the life sciences sector.

Products

Cytel provides a range of software solutions and services that support clinical trial design and implementation:

• East®: A statistical software platform used for trial design, including adaptive Bayesian methods and group sequential designs.

• StatXact and LogXact: Provide exact statistical methods and regression modeling.

• EnForeSys: Enrollment forecasting tool that applies advanced Monte Carlo methods to predict trial enrollment feasibility.

• LiveSLR®: Software for systematic literature reviews and data synthesis.

• Solara: A simulation platform that guides clinical study design and strategy.

Key Features of Products

• East®:

• Facilitates design of adaptive and group sequential trials.

• Equipped with modules for enrichment designs, dose escalation, and multi-arm multi-stage trials.

• LiveSLR®:

• Provides comprehensive systematic literature reviews.

• Synthesizes data for high-quality research.

• Solara:

• Offers simulation-guided study design.

• Helps researchers select optimal study designs efficiently.

Recent Developments

• New Product Launch:

• East Horizon™: A new platform designed to empower biostatisticians and data scientists, facilitating advanced analytics and smarter decision-making in clinical trials.

• Partnerships:

• Cytel announced a strategic partnership with OneMedNet to enhance data-driven healthcare solutions.

• Recent Achievements:

• Cytel has released new Bayesian dose-finding methods within the East Bayes platform, tailored for improved clinical trial design.

• The TOGETHER Trial for COVID-19 therapies, designed by Cytel, won the Society of Clinical Trials best trial award and the Fierce Life Sciences Award in Technology Innovation.

This detailed company profile of Cytel Inc. highlights its leadership in integrating data science and biostatistics innovation to optimize clinical trials and improve drug development timelines.